Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority

Executive Summary

• Ventripoint Diagnostics Ltd. announced a partnership with the Nisg’a Valley Health Authority (NVHA) to launch a “hub‑and‑spoke” cardiac imaging model for remote and Indigenous communities.
• The model uses Ventripoint’s AI‑enhanced VMS+™ system to convert standard 2D echocardiograms into MRI‑level 3‑dimensional measurements, enabling point‑of‑care diagnostics without the need for travel or costly MRI scans.
• Initial rollout targets NVHA as the first remote site, with future phases planned for additional First Nations communities across Canada, Arctic regions, and international rural/remote locations (Amazon, Africa, India, etc.).

Key Details

• Partnership Scope: Ventripoint provides its VMS+™ software and AI‑driven interpretation services; NVHA supplies the remote clinical sites and local healthcare providers.
• Model Design: Central “hub” with advanced cardiac imaging capabilities supports multiple “spoke” sites that capture ultrasound scans, enhance them via VMS+™, and transmit digitally for specialist review.
• Clinical Applications: Congenital heart disease, post‑surgical monitoring, chemotherapy‑related cardiotoxicity, pulmonary hypertension, heart failure, valve dysfunction.
• Geographic Expansion Plan:
• Phase 1 – NVHA (Nass Valley, BC) as pilot remote site.
• Phase 2 – Additional First Nations communities in British Columbia and across Canada.
• Phase 3 – Arctic regions of Canada.
• Phase 4 – Rural/northern communities worldwide, including the Amazon basin, Africa, India, and other MRI‑limited areas.
• Technology Highlights: VMS+™ delivers MRI‑level accuracy by reconstructing 3D volumetric images from standard 2D echocardiograms; compatible with all ultrasound vendors; holds regulatory approvals in the U.S., Europe, and Canada.
• Strategic Rationale: Improves access to high‑quality cardiac diagnostics, reduces patient travel costs and wait times, supports health sovereignty for Indigenous peoples, and positions Ventripoint as a global provider of AI‑driven cardiac imaging solutions.

Notable Quotes

“Through our collaboration with the Nisg’a Valley Health Authority, we are creating a scalable model of heart care that can extend from the Arctic to the Amazon, ensuring that everyone, regardless of geography, has access to advanced diagnostics.” – Hugh MacNaught, CEO, Ventripoint Diagnostics Ltd.

“Partnering with Ventripoint allows us to explore innovative tools that support more accurate diagnoses, faster treatment decisions, and truly patient‑centred care right here at home.” – Corinne McKay, CEO, Nisg’a Valley Health Authority

Forward‑looking statements are included; actual results may differ.